Cowen, Piper Jaffray, Nomura and Wedbush PacGrow assist with deal
By Devika Patel
Knoxville, Tenn.., Nov. 16 – Voyager Therapeutics, Inc. said the underwriters for its initial public offering of stock opted to exercise the deal’s $10.5 million greenshoe in full, lifting total proceeds of the offering to $80.5 million. The deal was announced Oct. 9 and priced for $70 million with the greenshoe on Nov. 10.
The company sold 5.75 million common shares at $14.00 each. Of the shares, 750,000 were part of the fully exercised greenshoe.
Cowen and Co. and Piper Jaffray were the bookrunners.
Proceeds will be used for clinical development, clinical trials, preclinical development, working capital and other general corporate purposes.
The clinical-stage gene therapy company is based in Cambridge, Mass. The company expects its stock to begin trading on the Nasdaq Global Select Market on Nov. 11 under the symbol “VYGR.”
| Issuer: | Voyager Therapeutics, Inc.
|
| Issue: | Common stock
|
| Amount: | $80.5 million, including $10.5 million greenshoe of shares
|
| Shares: | 5.75 million
|
| Price: | $14.00
|
| Warrants: | No
|
| Bookrunners: | Cowen and Co. and Piper Jaffray & Co.
|
| Co-managers: | Wedbush PacGrow and Nomura
|
| Announcement date: | Oct. 9
|
| Pricing date: | Nov. 10
|
| Settlement date: | Nov. 16
|
| Expected listing: | Nasdaq: VYGR
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
